GB992581A - Improvements in or relating to therapeutic compositions comprising steroids and thiamine derivatives - Google Patents

Improvements in or relating to therapeutic compositions comprising steroids and thiamine derivatives

Info

Publication number
GB992581A
GB992581A GB22357/61A GB2235761A GB992581A GB 992581 A GB992581 A GB 992581A GB 22357/61 A GB22357/61 A GB 22357/61A GB 2235761 A GB2235761 A GB 2235761A GB 992581 A GB992581 A GB 992581A
Authority
GB
United Kingdom
Prior art keywords
thiamine
steroids
relating
therapeutic compositions
thiamine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB22357/61A
Inventor
Jean Montandraud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
C E R S A SA
Original Assignee
C E R S A SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C E R S A SA filed Critical C E R S A SA
Priority to GB22357/61A priority Critical patent/GB992581A/en
Priority to BE618448A priority patent/BE618448A/en
Priority to US200050A priority patent/US3284304A/en
Priority to FR901141A priority patent/FR2136M/en
Publication of GB992581A publication Critical patent/GB992581A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51Thiamines, e.g. vitamin B1
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Pharmaceutical compositions having corticosteroid activity with reduced side-effects comprise a corticosteroid having anti-inflammatory action, e.g. cortisone, prednisone, prednisolone and 9-a -fluoro-hydrocortisone, and thiamine or at least one derivative thereof having vitamin B1 activity, e.g. the diacetate, the propyl disulphide or their hydrochlorides (i.e. derivatives in which the thiazole ring is opened) or thiamine hydrochloride or thiamine pyrophosphate hydrochloride. Specifications 741,250 and 749,307 are referred to.
GB22357/61A 1961-06-21 1961-06-21 Improvements in or relating to therapeutic compositions comprising steroids and thiamine derivatives Expired GB992581A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB22357/61A GB992581A (en) 1961-06-21 1961-06-21 Improvements in or relating to therapeutic compositions comprising steroids and thiamine derivatives
BE618448A BE618448A (en) 1961-06-21 1962-06-04 New compositions based on corticosteroids
US200050A US3284304A (en) 1961-06-21 1962-06-05 Compositions and methods of using corticosteroids and thiamine derivatives
FR901141A FR2136M (en) 1961-06-21 1962-06-19 New compositions based on corticosteroids.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB22357/61A GB992581A (en) 1961-06-21 1961-06-21 Improvements in or relating to therapeutic compositions comprising steroids and thiamine derivatives

Publications (1)

Publication Number Publication Date
GB992581A true GB992581A (en) 1965-05-19

Family

ID=10178090

Family Applications (1)

Application Number Title Priority Date Filing Date
GB22357/61A Expired GB992581A (en) 1961-06-21 1961-06-21 Improvements in or relating to therapeutic compositions comprising steroids and thiamine derivatives

Country Status (4)

Country Link
US (1) US3284304A (en)
BE (1) BE618448A (en)
FR (1) FR2136M (en)
GB (1) GB992581A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5626818A (en) * 1979-08-13 1981-03-16 Osaka Chem Lab Glucocorticoid drug

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2841527A (en) * 1955-11-07 1958-07-01 Us Vitamin Corp Medicinal emulsions
US2970944A (en) * 1958-04-04 1961-02-07 Merck & Co Inc Parenteral solutions of steroid phosphates stabilized with creatinines
US3105010A (en) * 1959-06-19 1963-09-24 Schering Corp Steroid-amino acid compositions for preventing negative nitrogen balance
US3067098A (en) * 1959-11-02 1962-12-04 Baxter Don Inc Intravenous nourishment of patients

Also Published As

Publication number Publication date
US3284304A (en) 1966-11-08
FR2136M (en) 1963-11-12
BE618448A (en) 1962-10-01

Similar Documents

Publication Publication Date Title
CA614181A (en) Photopolymerizable compositions, elements and processes
IE39738L (en) Triamcinolone derivative
GB992581A (en) Improvements in or relating to therapeutic compositions comprising steroids and thiamine derivatives
IL30594A0 (en) New pharmaceutical steroidal compositions,especially useful for treatment of climacteric disorders
GB888631A (en) Improvements in or relating to oral therapeutic compositions comprising steroids
BR6456127D0 (en) PROCESS FOR THE PREPARATION OF 1,5-BIS-DISIDRO-STEROIDS 4-UNSUBSTITUTED OR 4 MONO-SUBSTITUTES AND OF A THERAPEUTIC COMPOSITION WITH ACTIVITY OF STEROID HORMONES
FR1503504A (en) 15alpha and 15beta-methyl derivatives of hydrocortisone, prednisolone cortisone, prednisone and their esters
GB1061236A (en) Pharmaceutical compositions comprising anti-inflammatory steroids and anti-viral nucleosides
ES375060A1 (en) 21-esters of triamcinolone and triamcinolone acetonide and a method of preparing them
FR284M (en) Medicinal product based on 6 alpha-methyl-9 alpha-fluoro-11 beta, 17 alpha-dihydroxy-1,4-pregnadiene-3,20-dione for the treatment of amenorrhea.
CA750366A (en) .delta.2,4 steroid compounds of the androstane and pregnane series
AU260990B2 (en) Pharmacologically active 2-thenyl-guanidine derivatives, their preparation, and pharmaceutical compositions thereof
CA638839A (en) 9.beta.,11.beta.-OXIDO STEROID OF THE ANDROSTANE OR PREGNANE SERIES
CA626911A (en) Use of vitamin d in preventing hypercalcuria resulting from adrenal cortical steroid administration
CA616975A (en) PROCESS OF PREPARING 16.beta.-METHYL-1,4-PREGNADIENE-9.alpha.-FLUORO-11.beta.,17.alpha.,21-TRIOL AND 21-ACYLATE DERIVATIVES THEREOF
YU127868A (en) Process for preparing 4,6-dichloro- 4,6-steroids oftthe pregnane and androstane series
CA641908A (en) 12.alpha.-ALKYL-11.beta.,17.alpha.,21-TRIHYDROXY-4-PREGNENE-3,20-DIONE AND 9.alpha.-HALO DERIVATIVES THEREOF
CA740887A (en) 2-fluoro- and 6-fluoro-3-oxo-.delta.1,4-steroids of the androstane and pregnane series and process for the preparation thereof
AU269819B2 (en) Anew a-norb-homo steroid, processes for its preparation and pharmaceutical compositions thereof
CA641910A (en) 12.alpha.-ALKYL-11.beta.,17.alpha.,21-TRIHYDROXY-1,4-PREGNADIENE-3,20-DIONE AND 9.alpha.-HALO SUBSTITUTED DERIVATIVES THEREOF
CA615185A (en) 16.beta.-METHYL-1,4-PREGNADIENE-9,11-OXIDO-17.alpha.,21-DIOL-3,20-DIONE
GB1057437A (en) Improvements in or relating to í¸-dehydro-19-nor-progesterones
CA736940A (en) 16.beta.-METHYL STEROIDS OF THE PREGNANE SERIES AND PROCESSES FOR THEIR MANUFACTURE
FR1430053A (en) Preparation of 16 alpha-hydroxy steroids of the 6 alpha-methyl-4-pregnene-3, 20-dione series and their 16-acyl derivatives
AU268742B2 (en) 1,2,3,4,5,7-HEXAHYDRO-11b-H-BENZOPYRIDOCOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME